Letter: University isn’t a business

[ad_1] Nebraska Gov. Jim Pillen brought up the old “we will run state government like a business” angle that Republicans love to quote. After reading about the Nebraska Board of…

New tools improve fight against HIV, AIDS yet La Crosse experts say stigma slows diagnoses

[ad_1] Turning the AIDS epidemic into a treatable infection could be considered one of humanity’s greatest health care achievements. Some La Crosse health providers and patients have been on the…

‘It’s an excellent fit’: New Canada Excellence Research Chair in Antiviral Drug Design builds on U of A’s leadership in pandemic preparedness research

[ad_1] Drug discovery is all about finding a good fit — designing exactly the right drug to slow or stop progression of the disease you are targeting. To do that,…

Capital chatter: Breese-Iverson approaches session with business philosophy

[ad_1] Capital chatter: Breese-Iverson approaches session with business philosophy  Oregon Capital Insider [ad_2] Source link

Factbox: Some key facts about the mink industry in Europe

[ad_1] COPENHAGEN (Reuters) – Denmark, Europe’s largest exporter of mink pelts, said it will cull millions of the animals bred for their fur after COVID-19 infections were transmitted to their…

Dutch, Belgian patients re-infected with coronavirus – NOS report

[ad_1] AMSTERDAM, Aug 25 (Reuters) – A patient in the Netherlands and another in Belgium have been confirmed as having been re-infected with the coronavirus, Dutch national broadcaster NOS reported…

Merck & Co to buy immunology specialist Prometheus

[ad_1] Merck & Co has agreed to buy Prometheus Biosciences, which specialises in developing treatments for immune-modulated diseases, for $10.8 billion (£8.7 billion) in cash. The main focus of the…

Merck Strengthens Immunology Pipeline with Acquisition of Prometheus Biosciences, Inc. – Merck.com

[ad_1] April 16, 2023 6:00 am ET PRA023 is a novel, late-stage candidate for ulcerative colitis and Crohn’s disease and other autoimmune conditions Prometheus Biosciences’ comprehensive data set enables target…